Boston Scientific Corporation's Revenue
- Boston Scientific Corporation's annual revenue was $14.24B in fiscal year 2023. The annual revenue increased $1.56B from $12.68B (in 2022) to $14.24B (in 2023), representing a 12.29% year-over-year growth.
- Boston Scientific Corporation's quarterly revenue was $4.21B in the quarter ending Sep 2024. The quarterly revenue increased $682.00M from $3.53B (in Q3: June 2023) to $4.21B (in Q3: June 2024), representing a 19.34% year-over-year growth.
- The highest annual revenue for Boston Scientific Corporation was $14.24B in fiscal year 2023.
- The lowest annual revenue was $7.48B in fiscal year 2015.
- The average revenue was $10.47B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2015 - 2024):
Learn more about Boston Scientific Corporation's Revenue by Segment and Revenue by Region.
Check out competitors to Boston Scientific Corporation in a side-by-side comparison.
Explore additional financial metrics for Boston Scientific Corporation.
Definition of Revenue :
| 2014 | 7380000000.00 |
|---|---|
| 2015 | 7477000000.00 |
| 2016 | 8386000000.00 |
| 2017 | 9048000000.00 |
| 2018 | 9823000000.00 |
| 2019 | 10735000000.00 |
| 2020 | 9913000000.00 |
| 2021 | 11888000000.00 |
| 2022 | 12682000000.00 |
| 2023 | 14240000000.00 |
| Mar 2015 | 1768000000.00 |
|---|---|
| Jun 2015 | 1843000000.00 |
| Sep 2015 | 1888000000.00 |
| Dec 2015 | 1978000000.00 |
| Mar 2016 | 1964000000.00 |
| Jun 2016 | 2126000000.00 |
| Sep 2016 | 2105000000.00 |
| Dec 2016 | 2191000000.00 |
| Mar 2017 | 2160000000.00 |
| Jun 2017 | 2257000000.00 |
| Sep 2017 | 2222000000.00 |
| Dec 2017 | 2408000000.00 |
| Mar 2018 | 2379000000.00 |
| Jun 2018 | 2490000000.00 |
| Sep 2018 | 2393000000.00 |
| Dec 2018 | 2561000000.00 |
| Mar 2019 | 2493000000.00 |
| Jun 2019 | 2631000000.00 |
| Sep 2019 | 2707000000.00 |
| Dec 2019 | 2905000000.00 |
| Mar 2020 | 2543000000.00 |
| Jun 2020 | 2003000000.00 |
| Sep 2020 | 2659000000.00 |
| Dec 2020 | 2708000000.00 |
| Mar 2021 | 2752000000.00 |
| Jun 2021 | 3077000000.00 |
| Sep 2021 | 2932000000.00 |
| Dec 2021 | 3127000000.00 |
| Mar 2022 | 3026000000.00 |
| Jun 2022 | 3244000000.00 |
| Sep 2022 | 3170000000.00 |
| Dec 2022 | 3242000000.00 |
| Mar 2023 | 3389000000.00 |
| Jun 2023 | 3599000000.00 |
| Sep 2023 | 3527000000.00 |
| Dec 2023 | 3725000000.00 |
| Mar 2024 | 3856000000.00 |
| Jun 2024 | 4120000000.00 |
| Sep 2024 | 4209000000.00 |
2023
Boston Scientific Corporation's annual revenue was $14.24B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $3.39B(Q1: Mar 2023), $3.60B(Q2: Jun 2023), $3.53B(Q3: Sep 2023), $3.73B(Q4: Dec 2023) in fiscal year 2023.
2022
Boston Scientific Corporation's annual revenue was $12.68B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $3.03B(Q1: Mar 2022), $3.24B(Q2: Jun 2022), $3.17B(Q3: Sep 2022), $3.24B(Q4: Dec 2022) in fiscal year 2022.
2021
Boston Scientific Corporation's annual revenue was $11.89B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $2.75B(Q1: Mar 2021), $3.08B(Q2: Jun 2021), $2.93B(Q3: Sep 2021), $3.13B(Q4: Dec 2021) in fiscal year 2021.
2020
Boston Scientific Corporation's annual revenue was $9.91B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $2.54B(Q1: Mar 2020), $2.00B(Q2: Jun 2020), $2.66B(Q3: Sep 2020), $2.71B(Q4: Dec 2020) in fiscal year 2020.
2019
Boston Scientific Corporation's annual revenue was $10.74B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $2.49B(Q1: Mar 2019), $2.63B(Q2: Jun 2019), $2.71B(Q3: Sep 2019), $2.91B(Q4: Dec 2019) in fiscal year 2019.
2018
Boston Scientific Corporation's annual revenue was $9.82B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $2.38B(Q1: Mar 2018), $2.49B(Q2: Jun 2018), $2.39B(Q3: Sep 2018), $2.56B(Q4: Dec 2018) in fiscal year 2018.
2017
Boston Scientific Corporation's annual revenue was $9.05B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $2.16B(Q1: Mar 2017), $2.26B(Q2: Jun 2017), $2.22B(Q3: Sep 2017), $2.41B(Q4: Dec 2017) in fiscal year 2017.
2016
Boston Scientific Corporation's annual revenue was $8.39B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $1.96B(Q1: Mar 2016), $2.13B(Q2: Jun 2016), $2.11B(Q3: Sep 2016), $2.19B(Q4: Dec 2016) in fiscal year 2016.
2015
Boston Scientific Corporation's annual revenue was $7.48B in fiscal year 2023.
Boston Scientific Corporation's quarterly revenue was $1.77B(Q1: Mar 2015), $1.84B(Q2: Jun 2015), $1.89B(Q3: Sep 2015), $1.98B(Q4: Dec 2015) in fiscal year 2015.
| 2014 | 0 |
|---|---|
| 2015 | +1.31 |
| 2016 | +12.16 |
| 2017 | +7.89 |
| 2018 | +8.57 |
| 2019 | +9.28 |
| 2020 | -7.66 |
| 2021 | +19.92 |
| 2022 | +6.68 |
| 2023 | +12.29 |
| Q1: Mar 15 | -0.34 |
|---|---|
| Q2: Jun 15 | -1.60 |
| Q3: Sep 15 | 2.28 |
| Q4: Dec 15 | 4.82 |
| Q1: Mar 16 | 11.09 |
| Q2: Jun 16 | 15.36 |
| Q3: Sep 16 | 11.49 |
| Q4: Dec 16 | 10.77 |
| Q1: Mar 17 | 9.98 |
| Q2: Jun 17 | 6.16 |
| Q3: Sep 17 | 5.56 |
| Q4: Dec 17 | 9.90 |
| Q1: Mar 18 | 10.14 |
| Q2: Jun 18 | 10.32 |
| Q3: Sep 18 | 7.70 |
| Q4: Dec 18 | 6.35 |
| Q1: Mar 19 | 4.79 |
| Q2: Jun 19 | 5.66 |
| Q3: Sep 19 | 13.12 |
| Q4: Dec 19 | 13.43 |
| Q1: Mar 20 | 2.01 |
| Q2: Jun 20 | -23.87 |
| Q3: Sep 20 | -1.77 |
| Q4: Dec 20 | -6.78 |
| Q1: Mar 21 | 8.22 |
| Q2: Jun 21 | 53.62 |
| Q3: Sep 21 | 10.27 |
| Q4: Dec 21 | 15.47 |
| Q1: Mar 22 | 9.96 |
| Q2: Jun 22 | 5.43 |
| Q3: Sep 22 | 8.12 |
| Q4: Dec 22 | 3.68 |
| Q1: Mar 23 | 12.00 |
| Q2: Jun 23 | 10.94 |
| Q3: Sep 23 | 11.26 |
| Q4: Dec 23 | 14.90 |
| Q1: Mar 24 | 13.78 |
| Q2: Jun 24 | 14.48 |
| Q3: Sep 24 | 19.34 |
2023
Boston Scientific Corporation’s annual revenue increased +12.29% during fiscal year 2023 compared to 2022. It represents a growth of $1.56B from $12.68B (in 2022) to $14.24B (in 2023).
2022
Boston Scientific Corporation’s annual revenue increased +6.68% during fiscal year 2022 compared to 2021. It represents a growth of $794.00M from $11.89B (in 2021) to $12.68B (in 2022).
2021
Boston Scientific Corporation’s annual revenue increased +19.92% during fiscal year 2021 compared to 2020. It represents a growth of $1.98B from $9.91B (in 2020) to $11.89B (in 2021).
2020
Boston Scientific Corporation’s annual revenue decreased -7.66% during fiscal year 2020 compared to 2019. It represents a decline of -$822.00M from $10.74B (in 2019) to $9.91B (in 2020).
2019
Boston Scientific Corporation’s annual revenue increased +9.28% during fiscal year 2019 compared to 2018. It represents a growth of $912.00M from $9.82B (in 2018) to $10.74B (in 2019).
2018
Boston Scientific Corporation’s annual revenue increased +8.57% during fiscal year 2018 compared to 2017. It represents a growth of $775.00M from $9.05B (in 2017) to $9.82B (in 2018).
2017
Boston Scientific Corporation’s annual revenue increased +7.89% during fiscal year 2017 compared to 2016. It represents a growth of $662.00M from $8.39B (in 2016) to $9.05B (in 2017).
2016
Boston Scientific Corporation’s annual revenue increased +12.16% during fiscal year 2016 compared to 2015. It represents a growth of $909.00M from $7.48B (in 2015) to $8.39B (in 2016).
2015
Boston Scientific Corporation’s annual revenue increased +1.31% during fiscal year 2015 compared to 2014. It represents a growth of $97.00M from $7.38B (in 2014) to $7.48B (in 2015).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2023 | $14.24B | +12.29% |
| 2022 | $12.68B | +6.68% |
| 2021 | $11.89B | +19.92% |
| 2020 | $9.91B | -7.66% |
| 2019 | $10.74B | +9.28% |
| 2018 | $9.82B | +8.57% |
| 2017 | $9.05B | +7.89% |
| 2016 | $8.39B | +12.16% |
| 2015 | $7.48B | +1.31% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q3: Sep 24 | $4.21B | 19.34% |
| Q2: Jun 24 | $4.12B | 14.48% |
| Q1: Mar 24 | $3.86B | 13.78% |
| Q4: Dec 23 | $3.73B | 14.90% |
| Q3: Sep 23 | $3.53B | 11.26% |
| Q2: Jun 23 | $3.60B | 10.94% |
| Q1: Mar 23 | $3.39B | 12.00% |
| Q4: Dec 22 | $3.24B | 3.68% |
| Q3: Sep 22 | $3.17B | 8.12% |
| Q2: Jun 22 | $3.24B | 5.43% |
| Q1: Mar 22 | $3.03B | 9.96% |
| Q4: Dec 21 | $3.13B | 15.47% |
| Q3: Sep 21 | $2.93B | 10.27% |
| Q2: Jun 21 | $3.08B | 53.62% |
| Q1: Mar 21 | $2.75B | 8.22% |
| Q4: Dec 20 | $2.71B | -6.78% |
| Q3: Sep 20 | $2.66B | -1.77% |
| Q2: Jun 20 | $2.00B | -23.87% |
| Q1: Mar 20 | $2.54B | 2.01% |
| Q4: Dec 19 | $2.91B | 13.43% |
| Q3: Sep 19 | $2.71B | 13.12% |
| Q2: Jun 19 | $2.63B | 5.66% |
| Q1: Mar 19 | $2.49B | 4.79% |
| Q4: Dec 18 | $2.56B | 6.35% |
| Q3: Sep 18 | $2.39B | 7.70% |
| Q2: Jun 18 | $2.49B | 10.32% |
| Q1: Mar 18 | $2.38B | 10.14% |
| Q4: Dec 17 | $2.41B | 9.90% |
| Q3: Sep 17 | $2.22B | 5.56% |
| Q2: Jun 17 | $2.26B | 6.16% |
| Q1: Mar 17 | $2.16B | 9.98% |
| Q4: Dec 16 | $2.19B | 10.77% |
| Q3: Sep 16 | $2.11B | 11.49% |
| Q2: Jun 16 | $2.13B | 15.36% |
| Q1: Mar 16 | $1.96B | 11.09% |
| Q4: Dec 15 | $1.98B | 4.82% |
| Q3: Sep 15 | $1.89B | 2.28% |
| Q2: Jun 15 | $1.84B | -1.60% |
| Q1: Mar 15 | $1.77B | -0.34% |
Related
-
Agilent Technologies Revenue
-
Eli Lilly and Company Revenue
-
Stryker Corporation Revenue
-
Johnson & Johnson Revenue
-
AbbVie Revenue
-
Merck & Co. Revenue
-
Thermo Fisher Scientific Revenue
-
Abbott Laboratories Revenue
-
Danaher Corporation Revenue
-
Amgen Revenue
-
Pfizer Revenue
-
Bristol-Myers Squibb Company Revenue
-
Cigna Corporation Revenue
-
McKesson Corporation Revenue
-
Cardinal Health Revenue
-
Moderna Revenue
